Clinical Trial Update: A Roll-over Study With Rilpivirine for Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Who Participated in Rilpivirine Pediatric Studies [Phase 2]

View source ↗

Summary

Phase 2 rollover study of rilpivirine for HIV-1–infected participants who previously participated in rilpivirine pediatric studies; the trial is active but not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• Edurant (rilpivirine)

Snippet

Sponsor: Janssen Sciences Ireland UC | Conditions: Human Immunodeficiency Virus Type 1 | Phase 2 | Status: ACTIVE_NOT_RECRUITING